Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus
Barbara Sullivan(Ultragenyx Pharmaceutical (United States)), James Chung(Amgen (United States))
Cited by 73
Related Papers
No related papers found
Powered by citation graph analysis